OpenVSafe by OpenVAERS
Search V-safe

96F-18351-98759

2 vaccinations 11 coded responses 23 check-ins 11 free-text entries 5 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
809 / CO
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-19
    Registered in v-safe
  2. 2021-03-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-19
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  4. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea
    Adult check-in
  7. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness
    Adult check-in
  8. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-03-26
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-04-04
    Survey response — day 14, dose 1
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue fatigue fatigue. It hasnt gotten better since my vaccine and I cannot explain why
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-09
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-09
    Survey response — day 0, dose 2
    MedDRA: Cough, Wheezing — Feeling: Poor · Site: Pain, Itching · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Wheezing, coughing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Severe dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling, Itching · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Severe Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Swelling, Itching · Chills, Headache, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-04-16
    Health check-in — day 7, dose 2
    Feeling: Good · Headache, Joint pains, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  20. 2021-04-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-16
    Survey response — day 35, dose 2
    MedDRA: Dyspnoea, Infection — Feeling: Good · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Infection and breathing difficulties
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-16
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-05-22
    Survey response — day 42, dose 2
    MedDRA: Infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Infection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-22
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-07-09
    Survey response — 3 months, dose 2
    MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Mast cell activation syndrome
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-07-09
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  28. 2021-07-14
  29. 2021-10-08
    Survey response — 6 months, dose 2
    MedDRA: Blood immunoglobulin M increased, Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Worsening mast cell activation syndrome and positive for antibodies of IGM binding to TS-HDS
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-08
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2021-10-13
  32. 2022-04-09
    Survey response — 12 months, dose 2
    MedDRA: Muscular weakness, Pain, Pre-existing disease, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Weakness in arms and legs. New rashes and body aches that randomly occur (most likely due to mast cell activation syndrome).
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-04-09
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  34. 2022-04-11
  35. 2022-04-14

Vaccinations

DoseDateManufacturerCo-administered
12021-03-19Pfizer-BioNTech
22021-04-09Pfizer-BioNTech

Call center

5 call center cases

5 unsuccessful

See the call center timeline

Free text

Release 6 — day 14, dose 1

2021-04-04

Symptoms: Fatigue fatigue fatigue. It hasnt gotten better since my vaccine and I cannot explain why

Release 7 — day 0, dose 2

2021-04-09

Systemic reaction (other): Wheezing, coughing

Release 7 — days 1–6 daily, dose 2

2021-04-10

Systemic reaction (other): Dizziness

2021-04-11

Systemic reaction (other): Severe dizziness

2021-04-12

Systemic reaction (other): Severe Dizziness

2021-04-13

Systemic reaction (other): Dizziness

Release 8 — day 35, dose 2

2021-05-16

Symptoms: Infection and breathing difficulties

Release 8 — day 42, dose 2

2021-05-22

Symptoms: Infection

Release 9 — 3 months, dose 2

2021-07-09

Symptoms: Mast cell activation syndrome

Release 10 — 6 months, dose 2

2021-10-08

Symptoms: Worsening mast cell activation syndrome and positive for antibodies of IGM binding to TS-HDS

Release 11 — 12 months, dose 2

2022-04-09

Symptoms: Weakness in arms and legs. New rashes and body aches that randomly occur (most likely due to mast cell activation syndrome).

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlood immunoglobulin M increased · · ✓
SDCondition aggravated · · ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDInfection ✓ ✓ ✓
SDMuscular weakness · · ✓
SDPain · · ✓
SDPre-existing disease ✓ ✓ ✓
SDRash · · ✓
SROCough ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROWheezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release